PPHN Does Not Discriminate When Paxil® is Involved
Category: PPHN
There are many things in this world to which we are vulnerable; a large percentage of which are simply out of our control including environmental elements. But there are some things which are completely in our control although we may be unaware of that fact until we are presented with the information. Without this information, however, we are left exposed to the possible ramifications of our actions.
Paxil® is an extremely popular medication on the market today; part of the class of drugs known as Selective Serotonin Reuptake Inhibitors (SSRIs) and used to treat depression and anxiety in millions of people worldwide. In general, Paxil® is both effective in its goals and rather innocuous when it comes to side effects; most people suffer little to no side effects and certainly nothing that would stop them from taking a medication that helps them to counter their feelings of depression.
But on closer examination – something which many of us fail to do when taking prescription drugs – it is evident that Paxil® may not be so harmless after all; especially when it comes to taking the drug during pregnancy. In fact, the taking of Paxil® during pregnancy has been shown to increase a women’s likelihood of giving birth to a baby that suffers from Persistent Pulmonary Hypertension in the Newborn – or PPHN.
PPHN inhibits the natural breathing process in newborns. Instead of their arteries expanding in order to receive the flow of blood to and from the lungs, a child with PPHN experiences a continued constriction of the arteries; blood is not able to flow to the lungs and become oxygenated as it should and the baby is left vulnerable to respiratory distress and even respiratory failure.
The evidence that connects the taking of Paxil® during pregnancy is too strong to ignore; the onset of PPHN has been shown to be six times as likely if a woman takes Paxil® during her pregnancy – staggering statistics that should not be ignored.
Popularity: 38% [?]



